Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146017 | 0.95 | MAPK1 (0.54) | MAPK1TSHRALOX15HSD17B10LMNA | |
| SCHEMBL17138168 | 0.91 | KCNA3 (0.46) | TSHRALDH1A1MAOBL3MBTL1MEN1 | |
| SCHEMBL149899 | 0.90 | MAPK1 (0.56) | MAPK1TSHRALOX15HSD17B10LMNA | |
| SCHEMBL31267697 | 0.90 | MAPK1 (0.56) | MAPK1TSHRALOX15HSD17B10LMNA | |
| SCHEMBL17138208 | 0.90 | PRSS1 (0.46) | TSHRALDH1A1MAOBL3MBTL1MEN1 | |
| SCHEMBL17138189 | 0.86 | ALDH1A1 (0.51) | MAPK1TSHRALDH1A1L3MBTL1MEN1 | |
| SCHEMBL11312715 | 0.84 | MAPK1 (0.65) | MAPK1TSHRALOX15HSD17B10LMNA | |
| SCHEMBL31267799 | 0.83 | HPGD (0.57) | MAPK1TSHRHSD17B10LMNANPSR1 | |
| SCHEMBL13349919 | 0.81 | TSHR (0.50) | MAPK1TSHRALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL11338027 | 0.81 | ALDH1A1 (0.51) | TSHRALOX15HSD17B10LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9617276-B2 | Compounds and methods for treating AIDS and HIV infections | PURDUE RESEARCH FOUNDATION (US) | 2017-04-11 | — | — | US | disclosed |
| US-20150111962-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-04-23 | — | — | US | disclosed |
| US-8921349-B2 | Compounds and methods for treating AIDS and HIV infections | PURDUE RESEARCH FOUNDATION (US) | 2014-12-30 | — | — | US | disclosed |
| EP-2429290-B1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | PURDUE RESEARCH FOUNDATION (US) | 2014-01-01 | — | — | EP | disclosed |
| EP-2429290-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | Purdue Research Foundation (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20120059161-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | PURDUE RESEARCH FOUNDATION (US) | 2012-03-08 | — | — | US | disclosed |
| WO-2010132494-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | GHOSH ARUN K (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059161-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | CTSS, DNPEP, PEPD | MAPK1 4419/4885TSHR 4503/4885ALOX15 1356/4885 |
| US-20150111962-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | CTSS, DNPEP, PEPD | MAPK1 4419/4885TSHR 4503/4885ALOX15 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.